NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Investor082,

The initial outlays for production and the delays in reimbursement from any source except self pay in advance creates a significant cash flow situation that only Eden and a prior cash influx can really solve. Therefore, anyone suggesting that Edens is not really needed must have lots of cash they intend to lend the company or they are just looking for an excuse to set up a scenario that helps push the price down with a blame game and swing trade if that cash doesn’t show up. Sound like anyone you know?; ). For the record, I still believe 600+ paying patients can be treated within 1 year of approval; ). Best wishes.